Patent-Pending · For Men & Women · All Ages

A revolution in hormone delivery.

A new approach to hormone replacement therapy designed to mirror the body's own rhythm — providing steady, physiologic levels of hormone, continuously, the way nature intended.

Learn the science Support the research

24/7 continuous delivery Physiologic by design Non-duplicable · patent pending

Steady physiologic levels Continuous delivery, around the clock — no peaks, no troughs.

The Approach

Hormone therapy, reimagined from the body up.

Traditional hormone replacement methods deliver medication in spikes and valleys — pills, patches, injections, and pellets that introduce hormone in bursts the body never naturally experiences.

Our patent-pending delivery system is engineered to do something different: provide a constant, physiologic level of hormone, continuously, in the way the human endocrine system was designed to receive it.

See the prototype concepts →

Education

Understanding hormone replacement therapy.

HRT restores hormones the body no longer produces in adequate quantities — due to age, surgery, or endocrine disease. It is prescribed for both men and women across low testosterone, menopause, thyroid imbalance, post-surgical recovery, and more.

Limitations of traditional delivery

Oral pills create peaks and troughs in blood hormone levels
Injections produce supraphysiologic spikes, then sub-therapeutic lows
Patches and gels can yield inconsistent absorption
Pellets require minor surgical insertion and offer limited dose control
Side-effect profiles are often tied directly to non-physiologic delivery
Patient compliance and quality of life can suffer

The Nathanson approach

Designed to deliver hormone at a constant therapeutic level
Mimics the body's own continuous endogenous production
Engineered to reduce the side-effect burden of peak-and-trough dosing
Single, simplified delivery — no daily dosing decisions
Patent-pending mechanism, non-duplicable by current alternatives
Applicable across genders, ages, and indications

Hormone levels over time

Illustrative — the conceptual difference between peak/trough dosing and physiologic, continuous delivery.

InjectionWeekly

Oral / PatchDaily

Nathanson MethodContinuous

Categories of Future Use

One delivery platform. Many indications.

The continuous-delivery principle behind the Nathanson platform isn't tied to a single hormone or condition. It's a delivery architecture — applicable across the most widely prescribed and actively researched classes of hormonal and peptide therapy.

Testosterone

Continuous physiologic testosterone replacement for men with hypogonadism — designed to avoid the supraphysiologic peaks and sub-therapeutic troughs of weekly injection cycles.

Men's Health

Steady, all-day levels

No injection-cycle roller coaster — a constant therapeutic level engineered for stable energy, mood, and recovery.

Menopause

Estrogen and combined hormone delivery for women in perimenopause and menopause — steady systemic levels engineered to address symptoms without the variability of pills, patches, or pellets.

Women's Health

Consistent relief

Physiologic, continuous delivery designed to smooth out the swings that drive symptoms.

Weight Loss · GLP-1

Continuous administration of GLP-1 receptor agonists — a delivery architecture that may smooth the appetite, gastrointestinal, and tolerability profile associated with weekly injection dosing.

Metabolic

Smoother tolerability

Steady exposure instead of weekly spikes — engineered to ease the GI and appetite swings.

Dementia & Neurodegenerative

Investigational applications in hormone-responsive neurodegenerative conditions, where stable systemic exposure may be material to clinical outcomes.

Investigational

Stable exposure

Where consistency of systemic levels may matter most to outcomes.

Thyroid, Peptides & Other

Thyroid hormone replacement, growth and metabolic peptides, and additional indications where continuous physiologic delivery may improve upon current standards of care.

Platform

One architecture, many uses

The same continuous-delivery principle, extended across hormone and peptide classes.